These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8354620)

  • 21. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
    Johnston SR
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
    Kaufmann M; Rody A
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term tamoxifen therapy to control or to prevent breast cancer: laboratory concept to clinical trials.
    Jordan VC
    Prog Clin Biol Res; 1988; 262():105-23. PubMed ID: 3287387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen in postmenopausal women a safety perspective.
    Robinson E; Kimmick GG; Muss HB
    Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen responders selection by computerized contact thermography in benign breast disease.
    Cupceancu B; Mogoş I; Cotruţă C
    Endocrinologie; 1986; 24(2):115-22. PubMed ID: 3738400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.
    Jordan VC
    Annu Rev Pharmacol Toxicol; 1995; 35():195-211. PubMed ID: 7598491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined tamoxifen-lynestrenol treatment in benign breast disease.
    Cupceancu B
    Endocrinologie; 1985; 23(4):265-72. PubMed ID: 4089504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen for breast cancer.
    Med Lett Drugs Ther; 1978 May; 20(9):41-2. PubMed ID: 642872
    [No Abstract]   [Full Text] [Related]  

  • 33. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.
    Rutqvist LE; Cedermark B; Glas U; Mattsson A; Skoog L; Somell A; Theve T; Wilking N; Askergren J; Hjalmar ML
    J Natl Cancer Inst; 1991 Sep; 83(18):1299-306. PubMed ID: 1886157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.
    Jordan VC
    Br J Pharmacol; 1993 Oct; 110(2):507-17. PubMed ID: 8242225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of tamoxifen in prevention of breast cancer.
    Nayfield SG; Karp JE; Ford LG; Dorr FA; Kramer BS
    J Natl Cancer Inst; 1991 Oct; 83(20):1450-9. PubMed ID: 1920492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tamoxifen in the treatment of breast cancer].
    Charlier C; Colin C; Merville MP; Gielen J; Lambotte R; Plomteux G; Castronovo V
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(7):751-6. PubMed ID: 7822705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term tamoxifen treatment in benign breast diseases.
    Cupceancu B
    Endocrinologie; 1985; 23(3):169-77. PubMed ID: 4048817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors.
    Marchant DJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):561-86. PubMed ID: 7731635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of resistance to tamoxifen therapy in breast cancer.
    Morrow M; Jordan VC
    Arch Surg; 1993 Nov; 128(11):1187-91. PubMed ID: 8239980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiestrogens as chemopreventive agents in breast cancer: promise and issues in evaluation.
    Love RR
    Prev Med; 1989 Sep; 18(5):661-71. PubMed ID: 2694160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.